Maltitol Coated Granules are pharmaceutical-grade multiparticulate granules in which maltitol is incorporated as a coating or functional granulating layer around a suitable core material. Maltitol is a polyhydric alcohol derived from maltose and is widely used as a pharmaceutical excipient because of its water solubility, palatability, and formulation versatility. The current USP-NF monograph identifies maltitol as d-glucopyranosyl-d-glucitol with the molecular formula C₁₂H₂₄O₁₁, molecular weight 344.31, and CAS Number 585-88-6. USP-NF specifies maltitol at 92.0%–100.5% d-maltitol on an anhydrous basis.
Maltitol is described by the Food Chemicals Codex as a white crystalline material that is very soluble in water and slightly soluble in ethanol. These characteristics make maltitol useful when a water-soluble excipient or palatable carbohydrate-derived component is required in an oral formulation.
Maltitol Coated Granules are developed by applying a maltitol-containing layer to a suitable granule or core under controlled processing conditions. Depending on the formulation design, coating can be used to modify surface characteristics, improve handling, incorporate a soluble excipient layer, or support taste-masking strategies.
Published pharmaceutical research has investigated maltitol in granule-based taste-masking systems and reported successful taste masking when maltitol was incorporated using mixing and coating approaches. The performance of the finished granules depends on the core material, maltitol concentration, processing method, coating uniformity, and other formulation variables.
The coating process can be performed using suitable granulation or fluid-bed processing technology depending on the intended product design. Coating parameters such as spray rate, inlet conditions, atomization, drying conditions, coating solution or suspension characteristics, and endpoint control may influence the final granule properties.
Maltitol is used as a pharmaceutical excipient in different formulation-development applications. Research has evaluated maltitol in granulation systems and as a binder in wet-granulated formulations. Studies involving sugar alcohols have specifically investigated maltitol during high-speed mixer granulation, demonstrating its relevance to pharmaceutical granulation research.
Maltitol has also been investigated as a tableting excipient. Research on amorphous maltitol examined its physicochemical and compaction properties, while textured crystalline maltitol materials have been evaluated for direct-compression applications.
The performance of Maltitol Coated Granules depends on the complete formulation rather than maltitol alone. Important product-development characteristics may include:
These characteristics should be established according to the actual finished product specification and intended formulation application. Coating weight gain, particle-size limits, density values, and dissolution requirements are product-specific and should not be represented as universal Maltitol Coated Granules specifications without supporting analytical data.
Maltitol can be useful in oral formulation development where palatability and taste characteristics are important. Research has demonstrated the use of maltitol-containing granules in taste-masking approaches for orally disintegrating formulations.
Maltitol Coated Granules can therefore be considered for formulation systems where a water-soluble, palatable excipient layer is required. The final performance depends on the core material, coating composition, coating thickness, processing conditions, and intended dosage-form design.
Maltitol is very soluble in water, which can support its use in aqueous processing and formulation development.
During coating development, the solubility characteristics of maltitol need to be considered together with drying conditions and the properties of the core granules. Excessive moisture, inadequate drying, or inappropriate process conditions can affect granule flow, agglomeration, surface characteristics, and coating uniformity. Therefore, process optimization should be performed using the actual formulation and manufacturing equipment.
Quality control of Maltitol Coated Granules should distinguish between the maltitol raw-material requirements and the finished coated-granule specifications.
For maltitol, the current USP-NF definition specifies NLT 92.0% and NMT 100.5% d-maltitol on an anhydrous basis.
For the finished granules, additional tests may be established according to the intended application, including identification, assay where applicable, moisture, particle-size distribution, bulk and tapped density, flow characteristics, coating uniformity, and dissolution or other performance testing.
The actual acceptance criteria should be based on the approved product specification and validated analytical methods rather than applying generic numerical values to every coated-granule formulation.
Maltitol Coated Granules can provide flexibility for multiparticulate formulation development. The coated-granule approach allows formulation scientists to control the composition and characteristics of the granule surface while maintaining a defined particulate structure.
Depending on the formulation, the granules may be designed for incorporation into capsules, sachets, oral powders, multiparticulate dosage forms, or further compression processes. The final dosage-form application should be selected according to the physical properties and validated performance of the finished granules.